Medcann Industries, Inc.
NSRS
$0.0001
$0.000.00%
OTC PK
| 01/31/2012 | 10/31/2011 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 39.43% | 114.57% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 39.43% | 114.57% | |||
| Operating Income | -39.43% | -114.57% | |||
| Income Before Tax | -136.97% | -124.51% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -136.97% | -124.51% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -136.97% | -124.51% | |||
| EBIT | -39.43% | -114.57% | |||
| EBITDA | -38.42% | -127.48% | |||
| EPS Basic | -147.20% | -124.30% | |||
| Normalized Basic EPS | -147.18% | -124.27% | |||
| EPS Diluted | -147.20% | -124.30% | |||
| Normalized Diluted EPS | -147.18% | -124.27% | |||
| Average Basic Shares Outstanding | -4.25% | 0.23% | |||
| Average Diluted Shares Outstanding | -4.25% | 0.23% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||